Prime Global, the international medical communications and market access group, is delighted to welcome Emma Sutcliffe as Senior Vice President, Patient Insights and Solutions. Emma will lead on patient engagement and support Prime Global’s seven agencies and four consultancies to deliver patient-centric communications.
Emma has a strong heritage in patient engagement strategy, HCP and patient education, and developing patient-driven health solutions. Her background includes leadership roles with NexGen Healthcare Communications and McCann Health, as well as consulting appointments with leading pharma and biotech companies such as Grunenthal, Vertex, and Merck. She is also a lecturer in patient engagement and social and public health at the University of Cambridge.
“I’m passionate about building relationships between patients and pharma. True patient engagement delivers more value and better outcomes, so it should always be part of the conversation,” says Emma. “My approach fits with Prime Global’s values and People First ethos; I’m excited to join the team!”
Peter Agathangelou, Executive Director of Strategy and Innovation at Prime Global, says, “I’m thrilled to welcome Emma! With her patient engagement leadership and focus on incorporating patient voice throughout the drug development journey, I look forward to working with her.”
Prime Global has experienced exceptional growth in recent years, including the recent launches of Prime Access, a Market Access consultancy, high-level strategy consultancy IRIS, and omic-based technical consultancy Prime Omics, as well as the acquisition of Cambridge Medical Communication. The company is proud to rank on several business growth lists such as the Sunday Times Fast Track 100 in 2018, 2019, and 2020, and featuring in the top ten of the Alantra Fast Pharma 50 in 2019, 2020, and 2021.